Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment

BACKGROUND: Treatment-resistant depression (TRD) has a profound cost to patients and healthcare services worldwide. Pharmacological augmentation is one therapeutic option for TRD, with lithium and quetiapine currently recommended as first-line agents. Patient opinions about pharmacological augmentat...

Descripción completa

Detalles Bibliográficos
Autores principales: McKeown, Lucas, Taylor, Rachael W, Day, Elana, Shah, Rupal, Marwood, Lindsey, Tee, Helena, Kerr-Gaffney, Jess, Oprea, Emanuella, Geddes, John R, McAllister-Williams, R Hamish, Young, Allan H, Cleare, Anthony J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112618/
https://www.ncbi.nlm.nih.gov/pubmed/35475375
http://dx.doi.org/10.1177/02698811221089042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112618/
https://www.ncbi.nlm.nih.gov/pubmed/35475375
http://dx.doi.org/10.1177/02698811221089042

Ejemplares similares